Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Neuro-Oncology
|
March 28, 2015
Phosphohistone H3: implications for clinical practice and risk assessment in meningioma
Adriana Olar
Seminars in Radiation Oncology
|
June 9, 2015
Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification
Adriana Olar, Erik P Sulman
The Journal of Pathology
|
October 12, 2013
Using the molecular classification of glioblastoma to inform personalized treatment
Adriana Olar, Kenneth D Aldape
Acta Neuropathologica Communications
|
February 5, 2020
Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma
Maria-Magdalena Georgescu, Adriana Olar
Current Treatment Options in Oncology
|
September 8, 2012
Biomarkers classification and therapeutic decision-making for malignant gliomas
Adriana Olar, Kenneth D Aldape
Oncology (Williston Park, N.Y.)
|
August 6, 2013
Molecular classification of diffuse gliomas
Adriana Olar, Sujit S Prabhu
Academic Forensic Pathology
|
June 27, 2019
A Pediatric Case of Diffuse Glioma Diagnosed at Autopsy
Jennifer Ross, Adriana Olar, Christine Fuller
Cancer Reports (Hoboken, N.J.)
|
July 29, 2020
Current clinical management of patients with glioblastoma
Stephen Lowe, Krishna P Bhat, Adriana Olar
Neuro-Oncology
|
February 27, 2016
Next-generation sequencing of central nervous systems tumors: the future of personalized patient management
Leomar Y Ballester, Adriana Olar, Sinchita Roy-Chowdhuri
Journal of Neurosurgery. Case Lessons
|
May 19, 2025
Calcifying pseudoneoplasm of the neuraxis progressing to G5/PDGFRA subgroup glioblastoma in a United States Army veteran with a history of head trauma and germline POT1 and EPHB2 mutations: illustrative case
Maria-Magdalena Georgescu, Adriana Olar, William Daniel Zollinger
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Neuro-Oncology
|
March 28, 2015
Phosphohistone H3: implications for clinical practice and risk assessment in meningioma
Adriana Olar
Seminars in Radiation Oncology
|
June 9, 2015
Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification
Adriana Olar, Erik P Sulman
The Journal of Pathology
|
October 12, 2013
Using the molecular classification of glioblastoma to inform personalized treatment
Adriana Olar, Kenneth D Aldape
Acta Neuropathologica Communications
|
February 5, 2020
Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma
Maria-Magdalena Georgescu, Adriana Olar
Current Treatment Options in Oncology
|
September 8, 2012
Biomarkers classification and therapeutic decision-making for malignant gliomas
Adriana Olar, Kenneth D Aldape
Oncology (Williston Park, N.Y.)
|
August 6, 2013
Molecular classification of diffuse gliomas
Adriana Olar, Sujit S Prabhu
Academic Forensic Pathology
|
June 27, 2019
A Pediatric Case of Diffuse Glioma Diagnosed at Autopsy
Jennifer Ross, Adriana Olar, Christine Fuller
Cancer Reports (Hoboken, N.J.)
|
July 29, 2020
Current clinical management of patients with glioblastoma
Stephen Lowe, Krishna P Bhat, Adriana Olar
Neuro-Oncology
|
February 27, 2016
Next-generation sequencing of central nervous systems tumors: the future of personalized patient management
Leomar Y Ballester, Adriana Olar, Sinchita Roy-Chowdhuri
Journal of Neurosurgery. Case Lessons
|
May 19, 2025
Calcifying pseudoneoplasm of the neuraxis progressing to G5/PDGFRA subgroup glioblastoma in a United States Army veteran with a history of head trauma and germline POT1 and EPHB2 mutations: illustrative case
Maria-Magdalena Georgescu, Adriana Olar, William Daniel Zollinger
Page
of 7